Cytotoxicity and bioavailability assessment from thiamin-phospholipid complexation loaded Ajwain oil based self nanoemulsifying system

Poor bioavailability (<5%) of thiamin hydrochloride (TH) primarily relates to its impaired permeability across gut mucosa. To modulate its permeability, a dual system based approach consisting of phospholipid complexation embedded into a self nanoemulsifying system was investigated. Thiamin-Phospholipid Complex (TPC) was developed and its Ajwain oil (AJO)-based self nanoemulsifying formulations (SNFs) were evaluated. Formation of TPC complexation was resulted from molecular interactions held between free bases of thiamin and phospholipid (PL). FTIR characterization reveals that the amino group (-NH2) in the free base of thiamin was physically interacted to phosphate linkage in PL. Single endothermic event in TPC & TH, reveals complexation between PL & free bases as interpreted from DSC data. Their corresponding melting point was 127 degrees C and 258 degrees C, respectively. Heat of fusion (Delta H-f) in TPC was higher than TH or PL. TPC exhibits a poor conductive environment over TH when diluted with ethanol/Tween20 (T2) medium. Lipophilic character of TPC was confirmed from partition coefficient (log P). Exact combination where ternary components produced fully dilutable nanoemulsion system, was identified using ternary diagram drawn between AJO (incorporated with TPC) as oil phase, and Tween20/Polyethylene glycol 600 (PEG600) as Surfactant/co-surfactant (S-mix) at ratios 1:1; 1:2 & 2:1. Seven TPC-loaded self nanoemulsifying formulations (SNFs) were designed which, upon subjected to aqueous phase dilution yielded nanoemulsion with droplet size range 95-190 nm with zeta potential -1.78 +/- 0.10 mV. Conductivity and Refractive index (RI) data of SNFs were in the range of 98 +/- 7.0 to 231 +/- 27 lS/ cm and 1.458 to 1.463 units, respectively. In vitro TH release from SNF was determined in hydro-chloric (HCl) buffer at pH 1.2, and in phosphate buffer solution (PB) at pH 6.8, data interpretation reveals that TPC delayed the release pattern compared to TH and could be attributed to lipophilic behavior of TPC. Intestinal permeability of drug was assessed from optimized SNF (F1) vs. TH across intestinal gut sac model (Apical to basolateral A -> B) resulted in a significant difference in permeability coefficient (1.09 x 10(-5)cm/h). Antioxidant potential of SNF was demonstrated in the DPPH method. MTT assay of TPC formulation conducted on MCF-7 and MDA-MB-231 (Breast cancer) cell lines showed the developed system from AJO possessed cytotoxicity effect. Pharmacokinetic assessment showed that optimized SNFs produced more than four-fold enhancement in bioavailability over control (TH solution) in the Wistar rat model. Meanwhile Area under curve (AUC) data obtained from TPC (in coarse emulsion) vs.TH produced a significant difference (p < 0.001). It can be concluded that developed SNFs via phospholipid complexation produced lipophilic transformation of TH and its SNFs modulated permeability as well as bioavailability enhancement of thiamin.